Fig. 13

Survival curves for model validation. (our model could be applied to different clinical groups: age, gender, lymph node metastasis, stage and T stage, P < 0.05)
Survival curves for model validation. (our model could be applied to different clinical groups: age, gender, lymph node metastasis, stage and T stage, P < 0.05)